Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 69664-69665 [E8-27447]
Download as PDF
<![CDATA[
69664
Federal Register / Vol. 73, No. 224 / Wednesday, November 19, 2008 / Notices
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
‘‘Evaluation of Pharmacy Syringe
Access Linked to HIV Testing for
Injection Drug Users in New York City
(Pharm-HIV)’’—New—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP). Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
HIV continues to be one of the leading
causes of illness and death in the US,
especially among black and Hispanic
communities. For injection drug users
(IDU), who are at high risk of acquiring
HIV infection, HIV testing may not be
readily accessible. In 2001, the New
York State Legislature established an
Expanded Syringe Access
Demonstration Program (ESAP) in New
York City which made syringes
available through participating
City; ten of which will test a model that
refers injection-drug-using syringe
customers for HIV testing to local HIV
testing sites. Two ESAP pharmacies will
evaluate the feasibility of offering and
performing HIV counseling and testing
in the pharmacy for injection-drug-using
syringe customers.
Two types of respondents will
provide the individual-level data; fortyeight adult (age ≥18 yrs) pharmacy staff
members will be surveyed to learn about
pharmacy staff attitudes and behaviors
regarding HIV testing and referral. The
other respondent group will be 442
adult (age ≥18 yrs) injection-drug-using
syringe customers who will complete a
brief quantitative interview after HIV
referral or HIV testing is offered to them.
HIV-seropositive injection-drug-using
syringe customers identified during HIV
testing will be immediately linked to
social and medical services. There is no
cost to respondents other than their
time.
pharmacies for injection drug users.
ESAP thus helped to reduce the burden
of HIV by increasing access to sterile
syringe sources. The ESAP allows for
regular contact between pharmacists
and their injection-drug-using syringe
customers, thus paving the way for
pharmacies to act as access points to
health and social services among IDU
customers. The expansion of pharmacy
services to include referrals for
injection-drug-using syringe customers
is based on the successes of ESAP,
which provides many services beyond
syringe exchange.
This project involves two kinds of
studies: testing service models at
pharmacies and, interviewing
individuals regarding the availability of
syringes through pharmacies. For testing
service models CDC will collaborate
with the New York Academy of
Medicine (NYAM) to implement this
project for a period of three years.
The NYAM will identify 12 ESAP
pharmacies in East Harlem, New York
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
respondents
Types of data collection
Pharmacy telephone screening and enrollment form ......................................
Pharmacy staff surveys—baseline, every six months x 3, and at end of
study. ............................................................................................................
Pharmacy staff brief surveys—monthly except when 6 monthly surveys are
completed. ....................................................................................................
Pharmacy daily syringe sales log ....................................................................
Injection-drug-using syringe customer surveys ...............................................
Total ..........................................................................................................
Dated: November 7, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–27448 Filed 11–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
cprice-sewell on PROD1PC64 with NOTICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
VerDate Aug<31>2005
15:14 Nov 18, 2008
Jkt 217001
1
10/60
4
48
5
20/60
80
12
12
442
19
600
1
10/60
5/60
30/60
38
600
221
........................
........................
........................
943
Time and Date: 9:30 a.m.–5 p.m.,
December 8, 2008.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without a
public comment period. To access by
conference call dial the following
information 1(866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
Frm 00066
Fmt 4703
Total burden
(in hours)
24
announces the following meeting for the
aforementioned subcommittee:
PO 00000
Average
burden per
response
(in hours)
Number of
responses per
respondent
Sfmt 4703
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
E:\FR\FM\19NON1.SGM
19NON1
Federal Register / Vol. 73, No. 224 / Wednesday, November 19, 2008 / Notices
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Discussed: The agenda for the
Subcommittee meeting includes: a discussion
of cases under review from the 6th, 7th, and
8th sets of individual dose reconstructions;
preparation of a letter report on the first 100
dose reconstruction cases reviewed; and, an
update on site-specific dose reconstruction
guidelines.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, GA 30333, Telephone (513) 533–
6800, Toll Free 1(800) CDC–INFO, e-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: November 13, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–27447 Filed 11–18–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
69665
Title: Letter of Intent for Indian
Tribes, Tribal organizations or Tribal
consortia to operate a title IV–E program
under the Fostering Connections to
Success and Increasing Adoptions Act
of 2008 (Pub. L. 110–351).
OMB No.: New Collection.
Description: The Administration for
Children and Families is requesting that
Indian tribes, tribal organizations or
tribal consortia that wish to apply for
direct title IV–E funding pursuant to
section 479B of the Social Security Act
send a letter expressing their intent to
facilitate budget and staff planning.
Respondents: Indian Tribes, Tribal
organizations and Tribal consortia.
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects:
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Letter of Intent .................................................................................................
cprice-sewell on PROD1PC64 with NOTICES
Instrument
562
1
1
562
Estimated Total Annual Burden
Hours: 562.
In compliance with the requirements
of section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
VerDate Aug<31>2005
15:14 Nov 18, 2008
Jkt 217001
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: November 13, 2008.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E8–27358 Filed 11–18–08; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0526]
Global Harmonization Task Force,
Study Group 1; Proposed and Final
Documents; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of proposed and final
documents that have been prepared by
Study Group 1 of the Global
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Harmonization Task Force (GHTF).
These documents represent a
harmonized proposal and
recommendation from the GHTF Study
Group that may be used by governments
developing and updating their
regulatory requirements for medical
devices. These documents are intended
to provide information only and do not
describe FDA’s current regulatory
requirements; elements of these
documents may not be consistent with
current U.S. regulatory requirements. In
particular, FDA seeks comments on the
advantages and disadvantages of the
approaches in the GHTF documents,
particularly where they are not
consistent with current practices for the
manufacture of products in the United
States.
DATES: Submit written or electronic
comments on these documents by
February 17, 2009. After February 17,
2009, written comments or electronic
comments may be submitted at any time
to the contact persons listed in this
document.
ADDRESSES: Submit written requests for
single copies of these documents to the
Division of Small Manufacturers,
International, and Consumer Assistance
(HFZ–220), Center for Devices and
Radiological Health, Food and Drug
E:\FR\FM\19NON1.SGM
19NON1
]]>Agencies
[Federal Register Volume 73, Number 224 (Wednesday, November 19, 2008)]
[Notices]
[Pages 69664-69665]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27447]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH), National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9:30 a.m.-5 p.m., December 8, 2008.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018. Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without a public comment period.
To access by conference call dial the following information 1(866)
659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: The Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advising the Secretary on whether there is a class
of employees at any Department of Energy facility who were exposed
to radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood
[[Page 69665]]
that such radiation doses may have endangered the health of members
of this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Discussed: The agenda for the Subcommittee meeting
includes: a discussion of cases under review from the 6th, 7th, and
8th sets of individual dose reconstructions; preparation of a letter
report on the first 100 dose reconstruction cases reviewed; and, an
update on site-specific dose reconstruction guidelines.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, GA
30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, e-mail
ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: November 13, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-27447 Filed 11-18-08; 8:45 am]
BILLING CODE 4163-18-P
